Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib

Benjamin Andrick; Abdulrahman Alwhaibi; David L DeRemer; Sameera Quershi; Rahil Khan; Locke J Bryan; Payaningal R Somanath; Jeremy Pantin

doi:10.1111/bjh.14855

Lack of adequate pneumococcal vaccination response in chronic lymphocytic leukaemia patients receiving ibrutinib

Br J Haematol. 2018 Sep;182(5):712-714. doi: 10.1111/bjh.14855. Epub 2017 Jul 24.

Authors

Benjamin Andrick^{1

2}, Abdulrahman Alwhaibi², David L DeRemer^{1

2

3}, Sameera Quershi³, Rahil Khan³, Locke J Bryan^{1

3

4}, Payaningal R Somanath^{2

3

5}, Jeremy Pantin^{1

3

4}

Affiliations

¹ Augusta University (AU) Medical Center, Augusta, GA, USA.
² Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA, USA.
³ Georgia Cancer Center, Augusta, GA, USA.
⁴ Division of Hematology/Oncology, Augusta University, Augusta, GA, USA.
⁵ Charlie Norwood VA Medical Center, Augusta, GA, USA.

PMID: 28737280
DOI: 10.1111/bjh.14855

No abstract available

Keywords: chronic lymphocytic leukaemia; ibrutinib; infection; pneumococcal.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adenine / analogs & derivatives
Aged
Case-Control Studies
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
Male
Middle Aged
Piperidines
Pneumococcal Vaccines / therapeutic use*
Prospective Studies
Pyrazoles / therapeutic use*
Pyrimidines / therapeutic use*
Time Factors
Treatment Outcome
Vaccination / trends*

Substances

13-valent pneumococcal vaccine
Piperidines
Pneumococcal Vaccines
Pyrazoles
Pyrimidines
ibrutinib
Adenine